Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection. Chuang MH, Wu JY, Liu TH, Hsu WH, et al. J Med Virol 2023;95:e28750.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chuang MH, Wu JY, Liu TH, Hsu WH, et al. Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection. J Med Virol 2023;95:e28750.
PMID: 37185834